Wednesday, September 27, 2023
Germany Latest News
  • Sports
  • USA
  • Asia
  • Health
  • Life Style
  • Tech
  • Science
  • Latin America
  • Africa
  • Europe
No Result
View All Result
Germany Latest News

BioNTech admits it will struggle to fill COVID vaccine ‘gap’

by The Editor
January 1, 2021
in Health
0
BioNTech admits it will struggle to fill COVID vaccine ‘gap’

Ugur Sahin, co-founder of the German vaccine developer BioNTech, is hoping to be able to boost production of the BioNTech-Pfizer vaccine by February, according to an interview with the Der Spiegel news magazine published on Friday.

The BioNTech executive also said he had been surprised by the European Union’s reticence towards purchasing enough supplies of the vaccine and warned that the current vaccine availability was not looking “rosy.”

Related posts

How Added Sugar And Salt Have Been Affecting Obesity Rates?

How Added Sugar And Salt Have Been Affecting Obesity Rates?

September 8, 2023
Why Plastic Water Bottles Should Be Banned?

Why Plastic Water Bottles Should Be Banned?

September 8, 2023

“We are lacking other approved vaccines and we have to fill this gap with our vaccine,” the Mainz-based company founder said.

Sahin said he was hopeful that, towards the end of January, the vaccine developer would have “clarity as to whether we can produce more and how much.”

This included the plan to have a new manufacturing facility in the city of Marburg up and running in February — “far earlier than planned” — which could produce a further 250 million doses in the first six months of 2021.

BioNTech-Pfizer faces limited production capacity

With its American partners at Pfizer, BioNTech is attempting to scale up production to meet the huge demand for a global immunization program.

While several other vaccines have been given the rubber stamp in different countries, the BioNTech-Pfizer vaccine was the first to gain approval in Europe and North America.

However, production faces extra challenges due to the complex technology behind it.

Sahin highlighted two main problems hampering increased production of the vaccine.

He explained to Der Spiegel that there is a lack of available facilities that can quickly be turned over to vaccine production.

“We are trying to find new cooperation partners to produce for us. But it’s not as if there were specialized unused factories lying around across the world that could produce vaccines of the required quality from one day to the next.”

The second major problem for producing the BioNTech-Pfizer vaccine is that the high complexity of the mRNA technology does not lend itself well to easy productive adaptability.

“You can’t just switch over, from producing vaccines instead of aspirin or cough syrup. The process requires years of expertise and the appropriate structural and technological equipment,” Sahin explained.

Delayed EU approval hampers vaccine roll-out

Despite receiving emergency approval in the US and UK several weeks ago, the BioNTech-Pfizer vaccine only received EU regulatory approval just days before Christmas.

EU countries have launched large-scale vaccination programs, but there are now concerns about whether there will be sufficient doses and whether demand can be met.

Fellow co-founder, and Sahin’s wife, Özlem Türeci, told the magazine that Brussels had assumed there would be a “basket of suppliers to choose from” due to the array of different vaccines in development.

This meant the EU ended up placing a relatively low order of just 300 million doses with BioNTech-Pfizer, and not until November. The US, on the other hand, ordered 600 million doses in July.

Both Bavarian State Premier Markus Söder and leader of the business-friendly FDP party Christian Lindner have called for vaccine production to be massively stepped up.

However, Sahin pointed out in his interview that part of the problem lay with the European Commission’s previous assumptions about vaccine availability. While the EU had pre-emptively ordered vaccines from BioNTech, they had also put in orders with other producers, yet these other vaccines have still not been approved.

“There was the assumption that many more companies would come with vaccines. Apparently, there was the impression that we [the EU] will get enough, it won’t be that bad and we [Brussels] have it under control. This surprised me,” Sahin said.

Read from source: https://www.dw.com/en/biontech-admits-it-will-struggle-to-fill-covid-vaccine-gap/a-56110454

 

Previous Post

Wall Street to kick out Chinese telecom giants

Next Post

New Year’s Eve — How to make resolutions for the new year

Next Post
New Year’s Eve — How to make resolutions for the new year

New Year's Eve — How to make resolutions for the new year

RECOMMENDED NEWS

Covid-19 case fatality rate below 2%, on continuous decline: Health ministry

Covid-19 case fatality rate below 2%, on continuous decline: Health ministry

3 years ago
Michael Avenatti Will Need Judges Permission To Practice Law In DC Or Maryland, Records Show

Michael Avenatti Will Need Judges Permission To Practice Law In DC Or Maryland, Records Show

5 years ago
NBA Playoffs, a Bonanza For Latino Players and Business

NBA Playoffs, a Bonanza For Latino Players and Business

5 years ago
Six cases of rare ‘polio-like’ illness diagnosed in children in Minnesota

Six cases of rare ‘polio-like’ illness diagnosed in children in Minnesota

5 years ago

FOLLOW US

  • 129 Followers
  • 87.2k Followers
  • 195k Subscribers

BROWSE BY CATEGORIES

  • Africa
  • Asia
  • Europe
  • Health
  • latest news
  • Latin America
  • Life Style
  • Mostbet
  • Science
  • Sports
  • Tech
  • Uncategorized
  • USA

BROWSE BY TOPICS

2018 League Bali United Beijing BlackBerry Brazil Broja Budget Travel Bundesliga California Champions League Chelsea China Chopper Bike Coronavirus COVID COVID-19 Crime Doctor Terawan EU France French German Istana Negara Italy Kazakhstan Market Stories Mexico National Exam Nigeria Omicron Pakistan Police protests Qatar Ronaldo Russia Smart Voting Sweden TikTok Trump UK Ukraine US vaccine Visit Bali
No Result
View All Result

Recent Posts

  • What Are the Pros and Cons of Sperm Freezing Technology?
  • How Tech Partnerships Can Keep the E-Commerce Boom Going?
  • Can robots be made more intelligent and smarter through reinforcement learning technology?
  • How Added Sugar And Salt Have Been Affecting Obesity Rates?
  • Why Plastic Water Bottles Should Be Banned?

Categories

  • Africa
  • Asia
  • Europe
  • Health
  • latest news
  • Latin America
  • Life Style
  • Mostbet
  • Science
  • Sports
  • Tech
  • Uncategorized
  • USA

Tags

2018 League Bali United Beijing BlackBerry Brazil Broja Budget Travel Bundesliga California Champions League Chelsea China Chopper Bike Coronavirus COVID COVID-19 Crime Doctor Terawan EU France French German Istana Negara Italy Kazakhstan Market Stories Mexico National Exam Nigeria Omicron Pakistan Police protests Qatar Ronaldo Russia Smart Voting Sweden TikTok Trump UK Ukraine US vaccine Visit Bali
Federal Government focuses on “integrated security”
latest news

Federal Government focuses on “integrated security”

by The Editor
June 14, 2023
0

Berlin (dpa) – The Federal Government is responding to the challenges of an increasingly unstable world order by means of a “policy...

Read more

Recent News

  • What Are the Pros and Cons of Sperm Freezing Technology?
  • How Tech Partnerships Can Keep the E-Commerce Boom Going?
  • Can robots be made more intelligent and smarter through reinforcement learning technology?

Category

  • Africa
  • Asia
  • Europe
  • Health
  • latest news
  • Latin America
  • Life Style
  • Mostbet
  • Science
  • Sports
  • Tech
  • Uncategorized
  • USA

Recent News

What Are the Pros and Cons of Sperm Freezing Technology?

What Are the Pros and Cons of Sperm Freezing Technology?

September 8, 2023
How Tech Partnerships Can Keep the E-Commerce Boom Going?

How Tech Partnerships Can Keep the E-Commerce Boom Going?

September 8, 2023
  • About
  • Advertise
  • Careers
  • Contact

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Sports
  • USA
  • Asia
  • Health
  • Life Style
  • Tech
  • Science
  • Latin America
  • Africa
  • Europe

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.